
Array Insights empowers patients and caregivers through AI-driven solutions, transforming patient experiences into actionable insights for healthcare research. Their flagship product, Tallulah, centralizes and analyzes patient stories, enabling organizations to streamline story management and enhance patient engagement. With a focus on patient advocacy organizations and pharmaceutical companies, Array Insights positions itself as a leader in patient-centric research, boasting over 1 million patients and thousands of insights generated. Their innovative approach and commitment to security differentiate them in the healthcare technology market, making them a compelling investment opportunity.

Array Insights empowers patients and caregivers through AI-driven solutions, transforming patient experiences into actionable insights for healthcare research. Their flagship product, Tallulah, centralizes and analyzes patient stories, enabling organizations to streamline story management and enhance patient engagement. With a focus on patient advocacy organizations and pharmaceutical companies, Array Insights positions itself as a leader in patient-centric research, boasting over 1 million patients and thousands of insights generated. Their innovative approach and commitment to security differentiate them in the healthcare technology market, making them a compelling investment opportunity.
What they do: AI-driven patient story management and data federation for patient advocacy orgs and research
Flagship product: Tallulah — AI patient story management platform
Founded / origins: Founded 2017; spun out of MIT
Funding signal: $4.7M seed (late 2022) and additional disclosed investments
Size: Approximately 8 employees
Fragmented patient and clinical data hinder patient-centered research and community engagement; Array Insights centralizes and analyzes patient stories and federated clinical data.
2017
Healthtech / AI for healthcare
$4.7M
Round included additional investors such as Mozilla Ventures, Future Labs, and York IE
0.00
Crunchbase lists a seed round with obfuscated amount
Company announced securing new investment enabling free access to Tallulah for patient advocacy organizations
“Led by Asset Management Ventures for a $4.7M seed; participation from Mozilla Ventures, Future Labs, and York IE”